Oral Anticoagulation for Patients With Atrial Fibrillation on Long-Term Hemodialysis

Review of 16studies (n=71,877) concludes oral anticoagulants (OAC) are not associated with reduced risk of thromboembolism in patients with AF on long-term dialysis; warfarin, dabigatran, and rivaroxaban were associated with significantly higher bleeding risk v apixaban or no OAC

Journal of the American College of Cardiology